Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
29.19B | 30.50B | 27.32B | 25.79B | 23.35B | 20.27B | Gross Profit |
4.37B | 4.26B | 4.47B | 5.06B | 4.88B | 3.50B | EBIT |
1.78B | 1.49B | 2.01B | 2.64B | 2.57B | 1.47B | EBITDA |
1.84B | 1.50B | 2.08B | 2.69B | 2.55B | 1.55B | Net Income Common Stockholders |
1.09B | 880.15M | 1.26B | 1.74B | 1.62B | 934.82M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.45B | 7.25B | 6.87B | 4.79B | 5.49B | 5.54B | Total Assets |
29.95B | 31.29B | 26.85B | 27.43B | 24.44B | 20.56B | Total Debt |
17.64B | 18.67B | 14.63B | 15.64B | 13.40B | 11.18B | Net Debt |
11.19B | 11.41B | 7.76B | 10.84B | 7.91B | 5.64B | Total Liabilities |
18.76B | 19.79B | 15.77B | 17.12B | 15.21B | 12.46B | Stockholders Equity |
11.19B | 11.49B | 11.08B | 10.30B | 9.23B | 8.10B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.11B | 3.57B | -2.34B | -1.56B | 1.00B | Operating Cash Flow |
0.00 | -1.60B | 4.55B | -706.53M | -1.28B | 2.75B | Investing Cash Flow |
0.00 | -1.62B | -1.25B | -1.55B | -434.60M | -1.75B | Financing Cash Flow |
0.00 | 3.54B | -1.50B | 1.58B | 1.67B | 905.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥10.14B | 54.06 | 3.81% | 0.43% | -91.24% | ||
72 Outperform | ¥9.62B | 10.46 | 5.42% | 11.64% | -30.51% | ||
68 Neutral | ¥9.11B | 4.74 | 4.59% | 13.64% | 128.96% | ||
66 Neutral | ¥8.57B | 4.25 | 1.75% | 6.93% | 63.41% | ||
61 Neutral | $2.83B | 10.72 | 0.40% | 6.10% | 5.80% | -21.26% | |
58 Neutral | ¥6.77B | 27.06 | ― | 341.55% | -0.36% | ||
54 Neutral | ¥8.62B | 114.71 | ― | 42.72% | -110.19% |